1. Epigenetic reprogramming of cortical neurons through alteration of dopaminergic circuits.
- Author
-
Brami-Cherrier, K, Anzalone, A, Ramos, M, Forne, I, Macciardi, F, Imhof, A, and Borrelli, E
- Subjects
Corpus Striatum ,Prefrontal Cortex ,Animals ,Mice ,Transgenic ,Dopamine ,Quinpirole ,Autoreceptors ,Receptors ,Dopamine D2 ,Histones ,Dopamine Agonists ,Psychotic Disorders ,Gene Expression ,Down-Regulation ,Epigenesis ,Genetic ,Dopaminergic Neurons ,Mice ,Transgenic ,Receptors ,Dopamine D2 ,Epigenesis ,Genetic ,Psychiatry ,Medical and Health Sciences ,Biological Sciences ,Psychology and Cognitive Sciences - Abstract
Alterations of the dopaminergic system are associated with the cognitive and functional dysfunctions that characterize complex neuropsychiatric disorders. We modeled a dysfunctional dopaminergic system using mice with targeted ablation of dopamine (DA) D2 autoreceptors in mesencephalic dopaminergic neurons. Loss of D2 autoreceptors abolishes D2-mediated control of DA synthesis and release. Here, we show that this mutation leads to a profound alteration of the genomic landscape of neurons receiving dopaminergic afferents at distal sites, specifically in the prefrontal cortex. Indeed, we observed a remarkable downregulation of gene expression in this area of ~2000 genes, which involves a widespread increase in the histone repressive mark H3K9me2/3. This reprogramming process is coupled to psychotic-like behaviors in the mutant mice. Importantly, chronic treatment with a DA agonist can revert the genomic phenotype. Thus, cortical neurons undergo a profound epigenetic reprogramming in response to dysfunctional D2 autoreceptor signaling leading to altered DA levels, a process that may underlie a number of neuropsychiatric disorders.
- Published
- 2014